Cargando…
Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study
BACKGROUND: Thromboelastometry is considered the best method to assesses hemostasis in liver disease. Diagnostic performance could be improved by adding protein C activators such as thrombomodulin or Protac®. We assessed changes in ROTEM parameters after the addition of Protac® in patients with acut...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744590/ https://www.ncbi.nlm.nih.gov/pubmed/36510196 http://dx.doi.org/10.1186/s12959-022-00438-3 |
_version_ | 1784848957232381952 |
---|---|
author | Calvo, Andrea Torrente, Miguel Angel Görlinger, Klaus Fernandez, Javier Reverter, Enric Vidal, Julia Tassies, Dolors Colmenero, Jordi Blasi, Annabel Reverter, Juan Carlos |
author_facet | Calvo, Andrea Torrente, Miguel Angel Görlinger, Klaus Fernandez, Javier Reverter, Enric Vidal, Julia Tassies, Dolors Colmenero, Jordi Blasi, Annabel Reverter, Juan Carlos |
author_sort | Calvo, Andrea |
collection | PubMed |
description | BACKGROUND: Thromboelastometry is considered the best method to assesses hemostasis in liver disease. Diagnostic performance could be improved by adding protein C activators such as thrombomodulin or Protac®. We assessed changes in ROTEM parameters after the addition of Protac® in patients with acute-on-chronic liver failure (ACLF), acute decompensation (AD), and healthy individuals (HI) to define different hemostasis patterns, considering standard and velocity ROTEM parameters, and assess whether Protac® can improve the definition of the pattern. METHODS: Pre-test, we investigated whether diluted EXTEM reagent improved the effect of Protac® on the clotting time (CT)-ratio with and without Protac®. Ten ACLF and 20 AD patients and 21 HI were included in the main study. RESULTS: Standard EXTEM was used in the main study. INTEM CFT, INTEM A5 (inverse), and INTEM TPI (inverse) were the parameters that best differentiated liver disease from HI (ROC AUC, 0.921, 0.906, and 0.928, respectively; all P-values < 0.001). Combining INTEM CFT with EXTEM LI60-ratio only slightly improved the diagnostic performance (ROC AUC, 0.948; P < 0.001). EXTEM LI60 and INTEM maxV-t were the parameters that best differentiated between ACLF and AD patients (ROC AUC, 0.743, P = 0.033; and 0.723, P = 0.050; respectively). Combining EXTEM LI60 + INTEM maxV-t moderately improved the diagnostic performance (ROC AUC, 0.81, P < 0.001). CONCLUSIONS: ROTEM velocity, fibrinolysis parameters and the indices calculated improve the diagnosis in combination with standard parameters (e.g., CFT and A5). Ratios calculated with and without Protac® (e.g., EXTEM LI60-ratio) only slightly increased the diagnostic performance in discriminating hemostasis patterns. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12959-022-00438-3. |
format | Online Article Text |
id | pubmed-9744590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97445902022-12-13 Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study Calvo, Andrea Torrente, Miguel Angel Görlinger, Klaus Fernandez, Javier Reverter, Enric Vidal, Julia Tassies, Dolors Colmenero, Jordi Blasi, Annabel Reverter, Juan Carlos Thromb J Research BACKGROUND: Thromboelastometry is considered the best method to assesses hemostasis in liver disease. Diagnostic performance could be improved by adding protein C activators such as thrombomodulin or Protac®. We assessed changes in ROTEM parameters after the addition of Protac® in patients with acute-on-chronic liver failure (ACLF), acute decompensation (AD), and healthy individuals (HI) to define different hemostasis patterns, considering standard and velocity ROTEM parameters, and assess whether Protac® can improve the definition of the pattern. METHODS: Pre-test, we investigated whether diluted EXTEM reagent improved the effect of Protac® on the clotting time (CT)-ratio with and without Protac®. Ten ACLF and 20 AD patients and 21 HI were included in the main study. RESULTS: Standard EXTEM was used in the main study. INTEM CFT, INTEM A5 (inverse), and INTEM TPI (inverse) were the parameters that best differentiated liver disease from HI (ROC AUC, 0.921, 0.906, and 0.928, respectively; all P-values < 0.001). Combining INTEM CFT with EXTEM LI60-ratio only slightly improved the diagnostic performance (ROC AUC, 0.948; P < 0.001). EXTEM LI60 and INTEM maxV-t were the parameters that best differentiated between ACLF and AD patients (ROC AUC, 0.743, P = 0.033; and 0.723, P = 0.050; respectively). Combining EXTEM LI60 + INTEM maxV-t moderately improved the diagnostic performance (ROC AUC, 0.81, P < 0.001). CONCLUSIONS: ROTEM velocity, fibrinolysis parameters and the indices calculated improve the diagnosis in combination with standard parameters (e.g., CFT and A5). Ratios calculated with and without Protac® (e.g., EXTEM LI60-ratio) only slightly increased the diagnostic performance in discriminating hemostasis patterns. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12959-022-00438-3. BioMed Central 2022-12-13 /pmc/articles/PMC9744590/ /pubmed/36510196 http://dx.doi.org/10.1186/s12959-022-00438-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Calvo, Andrea Torrente, Miguel Angel Görlinger, Klaus Fernandez, Javier Reverter, Enric Vidal, Julia Tassies, Dolors Colmenero, Jordi Blasi, Annabel Reverter, Juan Carlos Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study |
title | Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study |
title_full | Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study |
title_fullStr | Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study |
title_full_unstemmed | Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study |
title_short | Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study |
title_sort | haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of protac: a pilot study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744590/ https://www.ncbi.nlm.nih.gov/pubmed/36510196 http://dx.doi.org/10.1186/s12959-022-00438-3 |
work_keys_str_mv | AT calvoandrea haemostasispatternsinpatientswithacuteonchronicliverfailureandacutedecompensationofcirrhosisincludingthromboelastometrictestswithandwithouttheadditionofprotacapilotstudy AT torrentemiguelangel haemostasispatternsinpatientswithacuteonchronicliverfailureandacutedecompensationofcirrhosisincludingthromboelastometrictestswithandwithouttheadditionofprotacapilotstudy AT gorlingerklaus haemostasispatternsinpatientswithacuteonchronicliverfailureandacutedecompensationofcirrhosisincludingthromboelastometrictestswithandwithouttheadditionofprotacapilotstudy AT fernandezjavier haemostasispatternsinpatientswithacuteonchronicliverfailureandacutedecompensationofcirrhosisincludingthromboelastometrictestswithandwithouttheadditionofprotacapilotstudy AT reverterenric haemostasispatternsinpatientswithacuteonchronicliverfailureandacutedecompensationofcirrhosisincludingthromboelastometrictestswithandwithouttheadditionofprotacapilotstudy AT vidaljulia haemostasispatternsinpatientswithacuteonchronicliverfailureandacutedecompensationofcirrhosisincludingthromboelastometrictestswithandwithouttheadditionofprotacapilotstudy AT tassiesdolors haemostasispatternsinpatientswithacuteonchronicliverfailureandacutedecompensationofcirrhosisincludingthromboelastometrictestswithandwithouttheadditionofprotacapilotstudy AT colmenerojordi haemostasispatternsinpatientswithacuteonchronicliverfailureandacutedecompensationofcirrhosisincludingthromboelastometrictestswithandwithouttheadditionofprotacapilotstudy AT blasiannabel haemostasispatternsinpatientswithacuteonchronicliverfailureandacutedecompensationofcirrhosisincludingthromboelastometrictestswithandwithouttheadditionofprotacapilotstudy AT reverterjuancarlos haemostasispatternsinpatientswithacuteonchronicliverfailureandacutedecompensationofcirrhosisincludingthromboelastometrictestswithandwithouttheadditionofprotacapilotstudy |